Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Patients With Prader-Willi Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03458416
Recruitment Status : Recruiting
First Posted : March 8, 2018
Last Update Posted : June 11, 2019
Sponsor:
Information provided by (Responsible Party):
INSYS Therapeutics Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : May 2020